CLEC7A and Patent ductus arteriosus: In contrast, activation of Dectin-1 through systemic β-glucan administration, in combination with CD40 agonist antibody therapy was able to eliminate established tumors in a PDA mouse model, demonstrating a protective role for Dectin-1 (Wattenberg et al, 2023).